Can a cancer drug restore gout treatment? small study tests rituximab
NCT ID NCT06186219
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested whether a drug called rituximab could help people with severe, hard-to-treat gout respond again to a medication (pegloticase) that had stopped working for them. Only 2 people took part, and the main goal was to see if the approach was safe and possible. The study was completed, but results are not yet widely reported.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TOPHACEOUS GOUT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UCLA
Los Angeles, California, 90095, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.